AI-generated draft from CMS source. Review and verify clinical accuracy before use.
CLINICAL STAGE / CARE PATHWAY
Patient is currently in the therapeutic intervention phase of care after demonstrating moderate to severe chronic axial spinal pain predominantly in the lumbar or sacral region, with documented functional limitation and failure of noninvasive conservative management for at least 3 months. Clinical findings and diagnostic correlation support progression to neurolytic destruction of lumbar or sacral paravertebral facet joint nerve(s) under image guidance.
– Sequencing logic:
Neurolytic facet joint nerve destruction typically follows confirmation of pain source by at least two diagnostic medial branch blocks each providing consistent ≥80% pain relief, and prior therapeutic injections failing to provide sustained or adequate relief.
ICD-10 / DIAGNOSIS SUPPORT
Diagnosis support includes spondylosis, other specified dorsopathies, or ankylosing hyperostosis of the lumbar or lumbosacral region, consistent with the patient’s chronic axial spinal pain and functional impairment.
The documented diagnosis correlates with imaging findings, clinical exam, and previous diagnostic blocks confirming facet joint as pain generator.
– Example ICD-10 options:
M47.816 – Spondylosis without myelopathy or radiculopathy, lumbar region
M47.817 – Spondylosis without myelopathy or radiculopathy, lumbosacral region
M53.86 – Other specified dorsopathies, lumbar region
M53.87 – Other specified dorsopathies, lumbosacral region
SUBJECTIVE / HPI SUPPORT
Patient reports chronic low back pain localized to lumbar/sacral facet regions with axial, non-radicular quality, moderate to severe intensity, persisting >3 months despite prior conservative treatments. Pain significantly limits ability to stand, walk, perform ADLs, and disrupts sleep and work activities. Patient notes minimal to no sustained relief from conservative care and prior injections.
– Edit if needed:
low back pain
chronic axial pain
greater than 3 months
non-radicular
CONSERVATIVE CARE / PRIOR TREATMENT
Patient has undergone a minimum of 3 months of conservative management including physical therapy, physician-directed home exercise program, medication management including NSAIDs or muscle relaxants, and activity modification without adequate or sustained improvement.
The patient has had two or more diagnostic medial branch blocks each providing consistent ≥80% pain relief confirming facet as pain source, and subsequent therapeutic intraarticular or medial branch injections with less than 50% sustained benefit or contraindication to radiofrequency ablation.
– Common conservative care examples:
Formal physical therapy
NSAID therapy
Muscle relaxants
Home exercise program
Two diagnostic medial branch blocks
Therapeutic facet injections with poor response
OBJECTIVE / DIAGNOSTIC SUPPORT
Physical exam reveals localized tenderness over lumbar facet joints without signs of radiculopathy or neurogenic claudication.
Imaging studies including MRI or CT show degenerative changes consistent with facet arthropathy in lumbar or sacral region with no alternate pain generator such as fracture, tumor, or infection.
Documented diagnostic medial branch blocks produced consistent ≥80% pain relief, confirming facet joint nerve involvement suitable for neurolytic ablation.
ASSESSMENT
Assessment: Chronic lumbar/sacral facet joint mediated pain with functional impairment refractory to conservative care and prior therapeutic injections. The patient meets clinical and diagnostic criteria supporting medical necessity for lumbar/sacral facet joint neurolytic nerve destruction using image guidance.
PLAN / NEXT STEP
Plan: Proceed with image-guided destruction by neurolytic agent of lumbar or sacral paravertebral facet joint nerve(s) at the clinically indicated level(s) with appropriate bilateral or unilateral targeting based on symptoms and prior diagnostic results. Risks, benefits, and alternatives discussed.
– Edit if needed:
right-sided
left-sided
bilateral
lumbar levels
sacral levels
PROCEDURE-SPECIFIC CLINICAL REQUIREMENTS
The patient has had at least two diagnostic medial branch blocks with consistent ≥80% pain relief each.
Repeat neurolytic destruction procedures are supported only if prior RFA or neurolytic ablation provided ≥50% improvement in pain and functional status for ≥6 months.
Procedure must be performed under fluoroscopy or CT guidance for accuracy and safety; ultrasound or no imaging guidance is not supported.
Moderate or deep sedation, general anesthesia, or monitored anesthesia care (MAC) is generally not supported during facet neurolytic procedures unless medically necessary and documented (e.g., inability to cooperate, contraindications to procedure).
FOLLOW-UP / RESPONSE DOCUMENTATION
Patient follow-up includes assessment of pain relief using the same pain scale pre- and post-procedure, monitoring for at least 6 months.
Documented ≥50% improvement in pain severity and functional ability compared to baseline supports successful response.
Assessment of ADL improvement, pain-related disability, and tolerance to activities such as walking and standing is recorded.
– Edit if needed:
greater than 50% improvement
relief lasting six months or longer
MISSING DOCUMENTATION CHECK
– Documentation items to confirm:
Symptom duration
Functional limitation
Prior conservative care including therapy and medications
Diagnostic medial branch blocks with relief documented
Prior therapeutic injection response
Imaging correlation
Physical exam findings
Pain scores before and after procedure
Percent pain relief and duration
Specific levels and laterality treated
Diagnosis and ICD-10 support
APPEAL / PEER-TO-PEER CLINICAL SUPPORT
The requested lumbar/sacral facet joint neurolytic destruction is clinically supported by documented chronic facet-mediated pain unresponsive to conservative and prior injection therapies. Prior diagnostic blocks demonstrated consistent pain relief confirming the nerve source. The procedure is consistent with current clinical guidelines and supports medical necessity for improved pain control and functional restoration.
Clinical documentation validates functional impairment, diagnostic correlation, and rationale for the procedure to improve quality of life and reduce pain-related disability.
CMS MEDICARE FACET JOINT INTERVENTIONS COVERAGE GUIDANCE
COVERED SERVICES: Facet joint interventions for chronic axial neck or low back pain including intraarticular (IA) injections, medial branch blocks (MBB), radiofrequency ablations (RFA), and facet cyst rupture/aspiration.
CODING: Use CPT codes 64490-64495 for diagnostic/therapeutic injections by spinal region (cervical/thoracic or lumbar/sacral) with fluoroscopy or CT guidance only. Ultrasound-guided and non-image guided injections are non-covered. Use codes 64633-64636 for facet joint nerve neurolytic destruction (thermal RFA) with image guidance. Report bilateral procedures with modifier 50. Injection levels counted by number of facet joints (two joints per level bilateral counts as one level). One to two levels unilateral or bilateral allowed per session per spinal region. KX modifier required for diagnostic injections.
DIAGNOSTIC PROCEDURES: Indicated for diagnosis of facet syndrome in patients with moderate to severe chronic axial pain lasting ≥3 months, with failed conservative therapy, absence of untreated radiculopathy/non-facet pathology. Two diagnostic blocks per spinal region per 12 months allowed. Second diagnostic block at same level requires ≥80% consistent pain relief from first.
THERAPEUTIC PROCEDURES: Requires prior two diagnostic blocks with ≥80% relief each. Therapeutic injections require documentation why patient is not a candidate for RFA. Subsequent treatments require ≥50% pain relief or functional improvement lasting ≥3 months. Limited to four therapeutic joint sessions per spinal region per 12 months.
RADIOFREQUENCY ABLATION (RFA): Initial RFA requires prior two positive diagnostic MBBs. Repeat RFA allowed after ≥6 months if ≥50% pain relief or functional improvement documented. Limit two RFA sessions per spinal region per rolling 12 months.
FACET CYST ASPIRATION/ RUPTURE: Covered when advanced imaging confirms nerve root compression by cyst and symptoms documented. Repeat aspiration allowed once per cyst if ≥50% pain relief for ≥3 months.
LIMITATIONS/ DENIAL RISKS:
– Procedures without fluoroscopic or CT guidance, ultrasound guidance, MRI guidance, or no guidance not covered.
– Moderate/deep sedation, general anesthesia, or MAC not covered for injections; may be considered for RFA/cyst rupture with documented medical necessity (e.g. inability to cooperate, medical contraindications). Routine sedation for RFA not covered.
– More than two levels per session or more than four diagnostic or therapeutic sessions per spinal region annually denied.
– Biological agents or substances not FDA approved for facet injections lead to claim denial.
– Non-thermal facet denervation techniques billed with 64633-64636 are non-covered; should be coded as 64999 which is not covered for this use.
– Multiple blocks same day at same or nearby levels require medical necessity documentation; frequent same-day multiple blocks may trigger review.
– Intra-facet implants and procedures post anterior lumbar interbody fusion (ALIF) not covered.
– Diagnostic blocks at same level as prior successful RFA not covered.
– Facet joint procedures for generalized pain syndromes (e.g., fibromyalgia) are not reasonable and necessary.
DOCUMENTATION EXPECTATIONS: Medical records must document:
– Patient assessment related to facet pain complaint
– Relevant medical history and prior conservative treatment failure
– Baseline and post-procedure pain and disability scale measurements using consistent validated scales (e.g., NRS, VAS, ODI)
– Procedural details including levels, laterality, and imaging guidance
– Description of why patient is not candidate for RFA if therapeutic injection provided
– Medical necessity documentation for sedation if used
PROVIDER QUALIFICATIONS: Procedures must be performed by providers with appropriate training/credentialing via formal residency/fellowship or recognized certification covering anatomy, pharmacology, procedural skills, and imaging use. Non-physician providers may order and manage care within scope of state law.
FREQUENCY LIMITS SUMMARY:
– Diagnostic facet joint procedures: max 4 per spinal region per rolling 12 months
– Therapeutic facet joint injections: max 4 per spinal region per rolling 12 months
– Radiofrequency ablation: max 2 per spinal region per rolling 12 months
– Facet cyst aspiration/rupture: repeat once per cyst with documented benefit
BILLING NOTES:
– Report each spinal region separately using appropriate CPT codes
– Use modifier 50 to indicate bilateral interventions
– For ASC billing, ASC reports procedures with RT and LT modifiers and one unit per line; physicians continue using modifier 50
– KX modifier required on initial diagnostic injection claims; aberrant or repetitive use may trigger audit
– Claims lacking valid ICD-10 diagnosis code describing facet joint syndrome or related spondylosis conditions will be returned as incomplete
REFERENCES:
– Local Coverage Determination LCD L38773 Version 31
– CMS Article A58364 Version 37
– CMS IOM Manuals: Medicare Benefit Policy Manual Chapter 15 Section 50, NCD Manual Chapters on Prolotherapy, Acupuncture, CT; Claims Processing Manual Chapter 13; Program Integrity Manual Chapter 13
– CPT AMA 2020 Manual guidelines applied for coding and unit determination
Not clearly stated in source: Specific allowed ICD-10 codes beyond general facet joint and spondylosis diagnoses; detailed frequency for cyst aspiration beyond once repeat per cyst with documented benefit; sedation documentation requirements beyond examples given.